Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Seattle, Washington

Phase 1 colorectal cancer trials in Seattle, WA

24 Phase 1 colorectal cancer studies are recruiting participants at sites in Seattle as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Seattle at a glance

  • 24 studies are recruiting at a site in Seattle.
  • By phase: Phase 1 (10), Phase 1/2 (14).
  • By sponsor: industry (22), university, hospital or other (2).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in Seattle

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    Fred Hutchinson Cancer Research Center
    Registry record
    NCT05786924 · updated
  2. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT06253871 · updated
  3. A Study of VET3-TGI in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    KaliVir Immunotherapeutics
    Study site
    University of Washington, Fred Hutchinson Cancer Center
    Registry record
    NCT06444815 · updated
  4. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    Fred Hutchinson Cancer Research Center
    Registry record
    NCT06324357 · updated
  5. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Virginia Mason Medical Center
    Registry record
    NCT07488676 · updated
  6. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Virginia Mason Medical Center
    Registry record
    NCT07020221 · updated
  7. A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Swedish Cancer Institute
    Registry record
    NCT06663319 · updated
  8. First-in-human Study of 7MW4911 in GI Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mabwell (Shanghai) Bioscience Co., Ltd.
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT07216560 · updated
  9. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Fred Hutchinson Cancer Center / University of Washington
    Registry record
    NCT04657068 · updated
  10. T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Fred Hutchinson Cancer Center
    Study site
    Fred Hutch/University of Washington Cancer Consortium
    Registry record
    NCT06043713 · updated
  11. SMP-3124LP in Adults With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Sumitomo Pharma America, Inc.
    Study site
    University of Washington
    Registry record
    NCT06526819 · updated
  12. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    PMV Pharmaceuticals, Inc
    Study site
    University of Washington, Fred Hutchinson Cancer Center
    Registry record
    NCT04585750 · updated
  13. Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT06625775 · updated
  14. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT06445062 · updated
  15. A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ArriVent BioPharma, Inc.
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT07066657 · updated
  16. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Xencor, Inc.
    Study site
    Xencor Investigative Site
    Registry record
    NCT05433142 · updated
  17. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

    • Phase 1
    • Ages 18 to 100
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Study site
    University Of Washington
    Registry record
    NCT06562192 · updated
  18. Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Recursion Pharmaceuticals Inc.
    Study site
    Benaroya Research Institute at Virginia Mason
    Registry record
    NCT05552755 · updated
  19. BBO-11818 in Adult Subjects With KRAS Mutant Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT06917079 · updated
  20. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Virginia Mason Medical Center
    Registry record
    NCT05379985 · updated
  21. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    858 Therapeutics, Inc.
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT06395519 · updated
  22. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Clasp Therapeutics, Inc.
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT06778863 · updated
  23. A Study of NX-1607 in Adults With Advanced Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Study site
    Fred Hutchinson Cancer Center
    Registry record
    NCT05107674 · updated
  24. A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    A2 Biotherapeutics Inc.
    Study site
    Fred Hutch Cancer Center
    Registry record
    NCT06682793 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Seattle, WA on ClinicalTrials.gov.

Ask about studies near Seattle

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call